Average Insider

Where insiders trade, we follow

$HAE
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Healthcare
Sector
Medical - Instruments & Supplies
Industry
Christopher A. Simon
CEO
3657
Employees
$122.94
Current Price
$3.48B
Market Cap
52W Low$51.00
Current$122.9488.8% above low, 11.2% below high
52W High$132.00

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00--All Sells
Sells11$101,147.64836
2 weeksBuys00--All Sells
Sells11$101,147.64836
1 monthBuys00--All Sells
Sells11$101,147.64836
2 monthsBuys00--All Sells
Sells11$101,147.64836
3 monthsBuys00--All Sells
Sells11$101,147.64836
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Nov 11, 2026
Maunsell Farris Maryanne
VP, Chief Accounting Officer
Sale836$120.99$101,147.64View Details

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Nov 5, 2026
EPS
Estimated$1.29
ActualN/A
Revenue
Estimated$345.15M
ActualN/A
1 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.10.12